Home » Topics » Disease categories and therapies » Immune

Immune
RSS

FDA approval for Gamunex

Sep. 1, 2003

Novel p56lck inhibitors described with potent activity against T-cell proliferation

Aug. 29, 2003

New IMPDH inhibitors and their use in psoriasis, arthritis and transplant rejection

Aug. 26, 2003

Beneficial effects reported for FR-167653 in experimental autoimmune myocarditis

Aug. 26, 2003

Corixa and Apovia enter RC-529 agreement

Aug. 22, 2003

Health Canada approves Gamunex

Aug. 22, 2003

Pentostatin in children with chronic GVHD

Aug. 22, 2003

BMS claims new IMPDH inhibitors and their use in recent patent

Aug. 12, 2003

Advanced Biotherapy to study antibody therapy in organ transplant rejection

Aug. 5, 2003

AltaStaph enters phase II in low-birth-weight neonates

July 31, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...